Takeda Pharmaceutical (TAK) Buildings (2017 - 2019)

Takeda Pharmaceutical's Buildings history runs 3 years deep, the most recent figure standing at $1.1 billion for Q1 2019.

• On a quarterly basis, Buildings changed N/A year-over-year to $1.1 billion in Q1 2019; TTM through Mar 2019 was $1.1 billion, a N/A change from a year earlier, with the FY2019 full-year figure at $1.1 billion, changed N/A from the prior year.
• Buildings eased to $1.1 billion in Q1 2019 per TAK's latest filing, from $2.9 billion in the prior quarter.
• Across five years, Buildings topped out at $2.9 billion in Q4 2018 and bottomed at $1.1 billion in Q1 2019.
• The 3-year median for Buildings is $1.9 billion (2017), against an average of $2.0 billion.
• Biggest YoY gain for Buildings was 51.69% in 2018; the steepest drop was 51.69% in 2018.
• Year by year, Buildings stood at $1.9 billion in 2017, then soared by 51.69% to $2.9 billion in 2018, then slumped by 61.19% to $1.1 billion in 2019.
• Per Business Quant, the three latest TAK Buildings figures stand at $1.1 billion (Q1 2019), $2.9 billion (Q4 2018), and $1.9 billion (Q4 2017).